![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 25, 2012 12:25:10 PM
Press Release: QIAGEN N.V. – Tue, Jan 24, 2012 9:10 AM EST
Companies:
Qiagen NVQIAGEN NV
RELATED QUOTES
Symbol Price Change
QGEN 16.33 +0.64
VENLO, Netherlands, Jan. 24, 2012 (GLOBE NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN - News) today announced the Webcast of its fourth quarter and year-end 2011 financial results call. The Webcast will take place at 9:30 a.m. ET on Wednesday, February 1, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and Roland Sackers, Chief Financial Officer.
What: Webcast of QIAGEN's fourth quarter and year-end 2011 financial results call
When: 9:30 a.m. ET on February 1
Where: The Webcast is accessible at www.qiagen.com/goto/ConferenceCall
How: Log on to the Web at the address above
The corresponding presentation slides will be available for download in the investor relations section of QIAGEN's Web site at www.qiagen.com/goto/ConferenceCall.
QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as a "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics.
QIAGEN employs nearly 3,600 people in over 30 locations worldwide. Further information about QIAGEN can be found at http://www.qiagen.com/.
The QIAGEN N.V. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3692
Contact:
QIAGEN N.V.
ir@qiagen.com
phone +49 2103 2911709
Recent QGEN News
- QIAGEN to enhance the identification of human remains of Indigenous people and African Americans • GlobeNewswire Inc. • 07/08/2024 08:05:00 PM
- QIAGEN N.V. to release results for Q2 2024 and hold webcast • GlobeNewswire Inc. • 07/02/2024 01:29:56 PM
- QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children • GlobeNewswire Inc. • 06/27/2024 08:05:00 PM
- QIAGEN announces 2028 strategy for solid profitable growth • GlobeNewswire Inc. • 06/17/2024 11:30:00 AM
- QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs • GlobeNewswire Inc. • 06/13/2024 08:05:00 PM
- QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth • GlobeNewswire Inc. • 06/12/2024 08:05:00 PM
- QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance • GlobeNewswire Inc. • 06/11/2024 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/06/2024 08:50:44 PM
- QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period • GlobeNewswire Inc. • 06/06/2024 08:05:00 PM
- QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe • GlobeNewswire Inc. • 06/05/2024 08:05:00 PM
- QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care • GlobeNewswire Inc. • 06/03/2024 06:00:00 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 08:42:21 PM
- QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications • GlobeNewswire Inc. • 05/30/2024 09:55:30 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/30/2024 08:45:32 PM
- QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications • GlobeNewswire Inc. • 05/30/2024 08:05:00 PM
- QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine • GlobeNewswire Inc. • 05/29/2024 08:05:00 PM
- QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results • GlobeNewswire Inc. • 05/13/2024 06:00:00 AM
- QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- QIAGEN N.V. to release results for Q1 2024 and hold webcast • GlobeNewswire Inc. • 04/09/2024 01:48:45 PM
- QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024 • GlobeNewswire Inc. • 04/03/2024 08:05:00 PM
- QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system • GlobeNewswire Inc. • 03/25/2024 08:05:00 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM